Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein
Pulmonary fibrosis is a typical sequela of coronavirus disease 2019 (COVID-19), which is linked with a poor prognosis for COVID-19 patients. However, the underlying mechanism of pulmonary fibrosis induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Here, we demonstrat...
Saved in:
Published in | Cell chemical biology Vol. 30; no. 3; pp. 261 - 277.e8 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Ltd
16.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Pulmonary fibrosis is a typical sequela of coronavirus disease 2019 (COVID-19), which is linked with a poor prognosis for COVID-19 patients. However, the underlying mechanism of pulmonary fibrosis induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Here, we demonstrated that the nucleocapsid (N) protein of SARS-CoV-2 induced pulmonary fibrosis by activating pulmonary fibroblasts. N protein interacted with the transforming growth factor β receptor I (TβRI), to disrupt the interaction of TβRI-FK506 Binding Protein12 (FKBP12), which led to activation of TβRI to phosphorylate Smad3 and boost expression of pro-fibrotic genes and secretion of cytokines to promote pulmonary fibrosis. Furthermore, we identified a compound, RMY-205, that bound to Smad3 to disrupt TβRI-induced Smad3 activation. The therapeutic potential of RMY-205 was strengthened in mouse models of N protein-induced pulmonary fibrosis. This study highlights a signaling pathway of pulmonary fibrosis induced by N protein and demonstrates a novel therapeutic strategy for treating pulmonary fibrosis by a compound targeting Smad3.
[Display omitted]
•SARS-CoV-2-encoded N protein induces pulmonary fibrosis by activating lung fibroblasts•N protein disrupts the interaction of TβRI-FKBP12 to activate TβRI-Smad signaling•Compound RMY-205 binds to Smad3 to impair N protein-induced Smad3 activation•RMY-205 has good therapeutic potential for pulmonary fibrosis induced by N protein
Pulmonary fibrosis is a typical sequela of COVID-19. Zhang et al. demonstrate that the nucleocapsid (N) protein of SARS-CoV-2 induces pulmonary fibrosis by activating TβRI-Smad signaling in lung fibroblasts. Furthermore, they identify a compound, RMY-205, that inhibits N protein-activated Smad3 and has good therapeutic potential for N protein-induced pulmonary fibrosis. |
---|---|
AbstractList | Pulmonary fibrosis is a typical sequela of coronavirus disease 2019 (COVID-19), which is linked with a poor prognosis for COVID-19 patients. However, the underlying mechanism of pulmonary fibrosis induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Here, we demonstrated that the nucleocapsid (N) protein of SARS-CoV-2 induced pulmonary fibrosis by activating pulmonary fibroblasts. N protein interacted with the transforming growth factor β receptor I (TβRI), to disrupt the interaction of TβRI-FK506 Binding Protein12 (FKBP12), which led to activation of TβRI to phosphorylate Smad3 and boost expression of pro-fibrotic genes and secretion of cytokines to promote pulmonary fibrosis. Furthermore, we identified a compound, RMY-205, that bound to Smad3 to disrupt TβRI-induced Smad3 activation. The therapeutic potential of RMY-205 was strengthened in mouse models of N protein-induced pulmonary fibrosis. This study highlights a signaling pathway of pulmonary fibrosis induced by N protein and demonstrates a novel therapeutic strategy for treating pulmonary fibrosis by a compound targeting Smad3.
Pulmonary fibrosis is a typical sequela of COVID-19. Zhang et al. demonstrate that the nucleocapsid (N) protein of SARS-CoV-2 induces pulmonary fibrosis by activating TβRI-Smad signaling in lung fibroblasts. Furthermore, they identify a compound, RMY-205, that inhibits N protein-activated Smad3 and has good therapeutic potential for N protein-induced pulmonary fibrosis. Pulmonary fibrosis is a typical sequela of coronavirus disease 2019 (COVID-19), which is linked with a poor prognosis for COVID-19 patients. However, the underlying mechanism of pulmonary fibrosis induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Here, we demonstrated that the nucleocapsid (N) protein of SARS-CoV-2 induced pulmonary fibrosis by activating pulmonary fibroblasts. N protein interacted with the transforming growth factor β receptor I (TβRI), to disrupt the interaction of TβRI-FK506 Binding Protein12 (FKBP12), which led to activation of TβRI to phosphorylate Smad3 and boost expression of pro-fibrotic genes and secretion of cytokines to promote pulmonary fibrosis. Furthermore, we identified a compound, RMY-205, that bound to Smad3 to disrupt TβRI-induced Smad3 activation. The therapeutic potential of RMY-205 was strengthened in mouse models of N protein-induced pulmonary fibrosis. This study highlights a signaling pathway of pulmonary fibrosis induced by N protein and demonstrates a novel therapeutic strategy for treating pulmonary fibrosis by a compound targeting Smad3. Pulmonary fibrosis is a typical sequela of coronavirus disease 2019 (COVID-19), which is linked with a poor prognosis for COVID-19 patients. However, the underlying mechanism of pulmonary fibrosis induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Here, we demonstrated that the nucleocapsid (N) protein of SARS-CoV-2 induced pulmonary fibrosis by activating pulmonary fibroblasts. N protein interacted with the transforming growth factor β receptor I (TβRI), to disrupt the interaction of TβRI-FK506 Binding Protein12 (FKBP12), which led to activation of TβRI to phosphorylate Smad3 and boost expression of pro-fibrotic genes and secretion of cytokines to promote pulmonary fibrosis. Furthermore, we identified a compound, RMY-205, that bound to Smad3 to disrupt TβRI-induced Smad3 activation. The therapeutic potential of RMY-205 was strengthened in mouse models of N protein-induced pulmonary fibrosis. This study highlights a signaling pathway of pulmonary fibrosis induced by N protein and demonstrates a novel therapeutic strategy for treating pulmonary fibrosis by a compound targeting Smad3. [Display omitted] •SARS-CoV-2-encoded N protein induces pulmonary fibrosis by activating lung fibroblasts•N protein disrupts the interaction of TβRI-FKBP12 to activate TβRI-Smad signaling•Compound RMY-205 binds to Smad3 to impair N protein-induced Smad3 activation•RMY-205 has good therapeutic potential for pulmonary fibrosis induced by N protein Pulmonary fibrosis is a typical sequela of COVID-19. Zhang et al. demonstrate that the nucleocapsid (N) protein of SARS-CoV-2 induces pulmonary fibrosis by activating TβRI-Smad signaling in lung fibroblasts. Furthermore, they identify a compound, RMY-205, that inhibits N protein-activated Smad3 and has good therapeutic potential for N protein-induced pulmonary fibrosis. |
Author | Zhang, Zhi-yuan Ju, Cui-yu Gou, Tong Chen, Hang-zi Wu, Liu-zheng Wu, Qiao Chen, Xiao-yan Yan, Han Hong, Wen-bin Lin, Tianwei Wang, Bao-Rui Yang, Peng-bo Jiang, Zhi-hong Li, Fu-nan Wang, Wei-jia |
Author_xml | – sequence: 1 givenname: Zhi-yuan surname: Zhang fullname: Zhang, Zhi-yuan organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China – sequence: 2 givenname: Cui-yu surname: Ju fullname: Ju, Cui-yu organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China – sequence: 3 givenname: Liu-zheng surname: Wu fullname: Wu, Liu-zheng organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China – sequence: 4 givenname: Han surname: Yan fullname: Yan, Han organization: Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China – sequence: 5 givenname: Wen-bin surname: Hong fullname: Hong, Wen-bin organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China – sequence: 6 givenname: Hang-zi surname: Chen fullname: Chen, Hang-zi organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China – sequence: 7 givenname: Peng-bo surname: Yang fullname: Yang, Peng-bo organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China – sequence: 8 givenname: Bao-Rui surname: Wang fullname: Wang, Bao-Rui organization: Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China – sequence: 9 givenname: Tong surname: Gou fullname: Gou, Tong organization: Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China – sequence: 10 givenname: Xiao-yan surname: Chen fullname: Chen, Xiao-yan organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China – sequence: 11 givenname: Zhi-hong surname: Jiang fullname: Jiang, Zhi-hong organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China – sequence: 12 givenname: Wei-jia surname: Wang fullname: Wang, Wei-jia organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China – sequence: 13 givenname: Tianwei surname: Lin fullname: Lin, Tianwei email: twlin@xmu.edu.cn organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China – sequence: 14 givenname: Fu-nan surname: Li fullname: Li, Fu-nan email: fnlee5@xmu.edu.cn organization: Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China – sequence: 15 givenname: Qiao surname: Wu fullname: Wu, Qiao email: qiaow@xmu.edu.cn organization: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36889311$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkN1q3DAQhUXYkGyTvMKiF7AjyT-yb0LD0qaFlEL-IFfCHo2yWmzJyHZg374K213Sq17NwJxzZub7QhbOOyRkxVnKGS-vtylssG-t71LBRJYykTKWn5ClyAue1HleLY59UZ6Tq3HcMhadmeSZPCPnWVlVdcb5ktinDYZmwHmyQAc_oYMd9YaC7wc_O00ffr0mghXU-ECHueu9a8KOGtsGP9qRWqdnQE3bHX28fXhM1v4lEdTN0KGHZhitpkOIsdZdklPTdCNe_a0X5Pn7t6f1j-T-993P9e19ArnkU9JILowWBkUmGPCqRlbrCgpjTJaDhhKkbIuMlWCwQS0xr0RsUXCZyzZOLsjNPneY2x41oJtC06kh2D5ernxj1b8TZzfqzb-ruq4Zl1UMKPcBEF8cA5qjlzP1wV9t1YG_-uCvmFCRfzSuPm8-2g60o-DrXoDx_3eLQY1gI3HUNiBMSnv7vx1_AAM8nso |
CitedBy_id | crossref_primary_10_1016_j_virs_2024_03_009 crossref_primary_10_3390_biomedicines12030639 |
Cites_doi | 10.1016/j.febslet.2012.01.040 10.1091/mbc.12.9.2730 10.1038/s41591-020-1051-9 10.1126/scisignal.aav5183 10.1056/NEJMoa2119451 10.1038/s41579-022-00713-0 10.1016/S2213-2600(20)30225-3 10.1016/S0092-8674(00)80555-3 10.1038/nri3024 10.1038/nature12034 10.1111/imr.12977 10.1172/JCI119590 10.1038/nature02006 10.1038/nchembio.1406 10.1038/s41556-021-00710-0 10.1038/nrneph.2016.48 10.1016/j.molcel.2020.11.025 10.1016/j.tibs.2004.03.008 10.1093/emboj/16.17.5353 10.1016/j.rmed.2018.12.015 10.1021/jm0492002 10.1016/j.molcel.2020.05.004 10.1038/mi.2008.85 10.1084/jem.20110551 10.1124/mol.105.017483 10.1016/S2213-2600(21)00174-0 10.1038/s41586-021-03570-8 10.1016/S1097-2765(01)00332-X 10.1038/labinvest.3700376 10.1038/s41571-020-0403-1 10.1002/j.1460-2075.1996.tb01013.x 10.1074/jbc.M700636200 10.1038/cr.2008.327 10.1038/ki.1994.68 10.1093/emboj/16.13.3866 10.1038/ncomms14420 10.1016/j.trsl.2021.09.001 10.1136/jcp.41.4.467 10.1038/s41591-021-01283-z 10.1007/978-1-4939-8570-8_2 10.1007/s11427-021-1964-4 10.1126/science.abf1611 10.1016/j.cell.2021.11.033 10.1038/s41467-018-03609-x 10.1101/cshperspect.a022103 10.1038/s41579-021-00630-8 10.1016/S0140-6736(20)30185-9 |
ContentType | Journal Article |
Copyright | 2023 Elsevier Ltd Copyright © 2023 Elsevier Ltd. All rights reserved. 2023 Elsevier Ltd. 2023 Elsevier Ltd |
Copyright_xml | – notice: 2023 Elsevier Ltd – notice: Copyright © 2023 Elsevier Ltd. All rights reserved. – notice: 2023 Elsevier Ltd. 2023 Elsevier Ltd |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1016/j.chembiol.2023.02.004 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 2451-9448 2451-9456 |
EndPage | 277.e8 |
ExternalDocumentID | 10_1016_j_chembiol_2023_02_004 36889311 S2451945623000533 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 0R~ 457 53G AACTN AAEDW AAIAV AAKRW AALRI AAUCE AAVLU AAXUO ABJNI ABMAC ABMWF ACGFS ACIUM ADBBV ADJPV AFTJW AITUG ALKID ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS FCP FDB FIRID HH5 JIG KOO M41 O9- OK1 RCE ROL CGR CUY CVF ECM EIF NPM 0SF 186 AAEDT AAYXX ABVKL ADVLN AKAPO AKRWK CITATION EJD NCXOZ RIG SSZ 5PM |
ID | FETCH-LOGICAL-c471t-a712fd2fe2320c189e09d8c5fff34cdc6c77b5306cfeaed7e482cfee21747bb53 |
IEDL.DBID | ABVKL |
ISSN | 2451-9456 |
IngestDate | Tue Sep 17 21:30:17 EDT 2024 Fri Aug 23 02:25:30 EDT 2024 Wed Apr 12 01:20:51 EDT 2023 Fri Feb 23 02:37:52 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | SARS-CoV-2 compound RMY-205 N protein pulmonary fibrosis TGF-β/Smad pathway |
Language | English |
License | Copyright © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c471t-a712fd2fe2320c189e09d8c5fff34cdc6c77b5306cfeaed7e482cfee21747bb53 |
Notes | These authors contributed equally Lead contact |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC9990178 |
PMID | 36889311 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9990178 crossref_primary_10_1016_j_chembiol_2023_02_004 pubmed_primary_36889311 elsevier_sciencedirect_doi_10_1016_j_chembiol_2023_02_004 |
PublicationCentury | 2000 |
PublicationDate | 2023-03-16 |
PublicationDateYYYYMMDD | 2023-03-16 |
PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-16 day: 16 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Cell chemical biology |
PublicationTitleAlternate | Cell Chem Biol |
PublicationYear | 2023 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Del Valle, Kim-Schulze, Huang, Beckmann, Nirenberg, Wang, Lavin, Swartz, Madduri, Stock (bib28) 2020; 26 Yang, Rao (bib9) 2021; 19 Carlson, Asfaha, Ghent, Howard, Hartooni, Safari, Frankel, Morgan (bib8) 2020; 80 Wynn, Chawla, Pollard (bib26) 2013; 496 Riches, Martin (bib48) 2018; 1809 Chen, Liu, Massague (bib19) 1997; 16 Tamaki, Okuda, Ando, Iwamoto, Nakayama, Fujishima (bib29) 1994; 45 Wilson, Wynn (bib15) 2009; 2 Nakao, Imamura, Souchelnytskyi, Kawabata, Ishisaki, Oeda, Tamaki, Hanai, Heldin, Miyazono, ten Dijke (bib25) 1997; 16 Zhu, Wang, Clarke, Liu (bib24) 2007; 282 Wendisch, Dietrich, Mari, von Stillfried, Ibarra, Mittermaier, Mache, Chua, Knoll, Timm (bib12) 2021; 184 Nalbandian, Sehgal, Gupta, Madhavan, McGroder, Stevens, Cook, Nordvig, Shalev, Sehrawat (bib3) 2021; 27 Wojciech, Ahmad, Belaid-Choucair, Journé, Gallet, Dam, Daulat, Ndiaye-Lobry, Lahuna, Karamitri (bib20) 2018; 9 Ehrlich, Gutman, Knaus, Henis (bib35) 2012; 586 George, Wells, Jenkins (bib4) 2020; 8 Wang, Wang, Chen, Xing, Li, Zhang, Zhou, Zhang, Zhang, Bian (bib46) 2014; 10 Bian, Chen, Yang, Li, Zhang, Zhang, Wang, Zhao, Zhang, Chen (bib49) 2017; 8 Hinck, Mueller, Springer (bib34) 2016; 8 Qiao, Li, Zeng, Liu, Luo, Huang, Wang, Zhang, Quan, Shen (bib44) 2021; 371 Wang, Chen, Hu, Pan, Liang, Wu, Tang, Huang, Yu, Wu, Lan (bib33) 2022; 9 Mantovani, Cassatella, Costantini, Jaillon (bib27) 2011; 11 Huse, Muir, Xu, Chen, Kuriyan, Massagué (bib39) 2001; 8 Jinnin, Ihn, Tamaki (bib23) 2006; 69 Bai, Zhong, Gao (bib7) 2022; 65 Dijke, Hill (bib22) 2004; 29 Derynck, Budi (bib36) 2019; 12 Lamers, Haagmans (bib1) 2022; 20 Wang, Horby, Hayden, Gao (bib2) 2020; 395 Sime, Xing, Graham, Csaky, Gauldie (bib16) 1997; 100 Martin (bib45) 2005; 48 Michalski, Kurche, Schwartz (bib31) 2022; 241 Wu, Liu, Zhou, Yu, Li, Zhan, Ni, Fang, Lu, Ding (bib6) 2021; 9 Goumans, Mummery (bib41) 2000; 44 Derynck, Zhang (bib21) 2003; 425 Wang, Dai, Qin, Pan, Chu, Lou, Zhang, Yang, Huang, Lu, Zhou (bib10) 2021; 23 Hou, Luo, Chen, Chen, Bian, Wu, Zhou, Zhao, Liu, Wang (bib47) 2020; 78 Delorey, Ziegler, Heimberg, Normand, Yang, Segerstolpe, Abbondanza, Fleming, Subramanian, Montoro (bib13) 2021; 595 Andrews, Stowe, Kirsebom, Toffa, Rickeard, Gallagher, Gower, Kall, Groves, O'Connell (bib30) 2022; 386 Heukels, Moor, von der Thüsen, Wijsenbeek, Kool (bib32) 2019; 147 Wynn (bib40) 2011; 208 Meng, Nikolic-Paterson, Lan (bib11) 2016; 12 Derynck, Turley, Akhurst (bib43) 2021; 18 Ashcroft, Simpson, Timbrell (bib17) 1988; 41 Souchelnytskyi, ten Dijke, Miyazono, Heldin (bib18) 1996; 15 Huse, Chen, Massagué, Kuriyan (bib38) 1999; 96 Seki, Hong, Oh (bib42) 2006; 86 Wrighton, Lin, Feng (bib37) 2009; 19 John, Joseph, Jenkins, Tatler (bib5) 2021; 302 Hinz, Celetta, Tomasek, Gabbiani, Chaponnier (bib14) 2001; 12 Bai (10.1016/j.chembiol.2023.02.004_bib7) 2022; 65 Dijke (10.1016/j.chembiol.2023.02.004_bib22) 2004; 29 Hinck (10.1016/j.chembiol.2023.02.004_bib34) 2016; 8 Nakao (10.1016/j.chembiol.2023.02.004_bib25) 1997; 16 Qiao (10.1016/j.chembiol.2023.02.004_bib44) 2021; 371 Seki (10.1016/j.chembiol.2023.02.004_bib42) 2006; 86 Yang (10.1016/j.chembiol.2023.02.004_bib9) 2021; 19 Wrighton (10.1016/j.chembiol.2023.02.004_bib37) 2009; 19 Riches (10.1016/j.chembiol.2023.02.004_bib48) 2018; 1809 Wendisch (10.1016/j.chembiol.2023.02.004_bib12) 2021; 184 Meng (10.1016/j.chembiol.2023.02.004_bib11) 2016; 12 Hinz (10.1016/j.chembiol.2023.02.004_bib14) 2001; 12 Sime (10.1016/j.chembiol.2023.02.004_bib16) 1997; 100 Bian (10.1016/j.chembiol.2023.02.004_bib49) 2017; 8 Chen (10.1016/j.chembiol.2023.02.004_bib19) 1997; 16 Jinnin (10.1016/j.chembiol.2023.02.004_bib23) 2006; 69 Ehrlich (10.1016/j.chembiol.2023.02.004_bib35) 2012; 586 Hou (10.1016/j.chembiol.2023.02.004_bib47) 2020; 78 Derynck (10.1016/j.chembiol.2023.02.004_bib21) 2003; 425 Nalbandian (10.1016/j.chembiol.2023.02.004_bib3) 2021; 27 Delorey (10.1016/j.chembiol.2023.02.004_bib13) 2021; 595 Souchelnytskyi (10.1016/j.chembiol.2023.02.004_bib18) 1996; 15 Mantovani (10.1016/j.chembiol.2023.02.004_bib27) 2011; 11 Wilson (10.1016/j.chembiol.2023.02.004_bib15) 2009; 2 Ashcroft (10.1016/j.chembiol.2023.02.004_bib17) 1988; 41 Wu (10.1016/j.chembiol.2023.02.004_bib6) 2021; 9 Martin (10.1016/j.chembiol.2023.02.004_bib45) 2005; 48 Del Valle (10.1016/j.chembiol.2023.02.004_bib28) 2020; 26 George (10.1016/j.chembiol.2023.02.004_bib4) 2020; 8 Carlson (10.1016/j.chembiol.2023.02.004_bib8) 2020; 80 Huse (10.1016/j.chembiol.2023.02.004_bib39) 2001; 8 Zhu (10.1016/j.chembiol.2023.02.004_bib24) 2007; 282 Wang (10.1016/j.chembiol.2023.02.004_bib46) 2014; 10 Wang (10.1016/j.chembiol.2023.02.004_bib10) 2021; 23 John (10.1016/j.chembiol.2023.02.004_bib5) 2021; 302 Heukels (10.1016/j.chembiol.2023.02.004_bib32) 2019; 147 Lamers (10.1016/j.chembiol.2023.02.004_bib1) 2022; 20 Wang (10.1016/j.chembiol.2023.02.004_bib33) 2022; 9 Andrews (10.1016/j.chembiol.2023.02.004_bib30) 2022; 386 Wojciech (10.1016/j.chembiol.2023.02.004_bib20) 2018; 9 Wynn (10.1016/j.chembiol.2023.02.004_bib40) 2011; 208 Derynck (10.1016/j.chembiol.2023.02.004_bib36) 2019; 12 Goumans (10.1016/j.chembiol.2023.02.004_bib41) 2000; 44 Tamaki (10.1016/j.chembiol.2023.02.004_bib29) 1994; 45 Wang (10.1016/j.chembiol.2023.02.004_bib2) 2020; 395 Derynck (10.1016/j.chembiol.2023.02.004_bib43) 2021; 18 Huse (10.1016/j.chembiol.2023.02.004_bib38) 1999; 96 Michalski (10.1016/j.chembiol.2023.02.004_bib31) 2022; 241 Wynn (10.1016/j.chembiol.2023.02.004_bib26) 2013; 496 |
References_xml | – volume: 45 start-page: 525 year: 1994 end-page: 536 ident: bib29 article-title: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy publication-title: Kidney Int. contributor: fullname: Fujishima – volume: 9 start-page: 1216 year: 2018 ident: bib20 article-title: The orphan GPR50 receptor promotes constitutive TGFβ receptor signaling and protects against cancer development publication-title: Nat. Commun. contributor: fullname: Karamitri – volume: 425 start-page: 577 year: 2003 end-page: 584 ident: bib21 article-title: Smad-dependent and Smad-independent pathways in TGF-b family signalling publication-title: Nature contributor: fullname: Zhang – volume: 395 start-page: 470 year: 2020 end-page: 473 ident: bib2 article-title: A novel coronavirus outbreak of global health concern publication-title: Lancet contributor: fullname: Gao – volume: 282 start-page: 18327 year: 2007 end-page: 18338 ident: bib24 article-title: Activation of Mps1 promotes transforming growth factor-β-independent Smad signaling publication-title: J. Biol. Chem. contributor: fullname: Liu – volume: 12 start-page: 2730 year: 2001 end-page: 2741 ident: bib14 article-title: Alpha-smooth muscle actin expression upregulates fibroblast contractile activity publication-title: Mol. Biol. Cell contributor: fullname: Chaponnier – volume: 26 start-page: 1636 year: 2020 end-page: 1643 ident: bib28 article-title: An inflammatory cytokine signature predicts COVID-19 severity and survival publication-title: Nat. Med. contributor: fullname: Stock – volume: 12 year: 2019 ident: bib36 article-title: Specificity, versatility, and control of TGF-β family signaling publication-title: Sci. Signal. contributor: fullname: Budi – volume: 16 start-page: 3866 year: 1997 end-page: 3876 ident: bib19 article-title: Mechanism of TGFβ receptor inhibition by FKBP12 publication-title: EMBO J. contributor: fullname: Massague – volume: 19 start-page: 685 year: 2021 end-page: 700 ident: bib9 article-title: Structural biology of SARS-CoV-2 and implications for therapeutic development publication-title: Nat. Rev. Microbiol. contributor: fullname: Rao – volume: 241 start-page: 13 year: 2022 end-page: 24 ident: bib31 article-title: From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? publication-title: Transl. Res. contributor: fullname: Schwartz – volume: 8 start-page: 807 year: 2020 end-page: 815 ident: bib4 article-title: Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy publication-title: Lancet Respir. Med. contributor: fullname: Jenkins – volume: 44 start-page: 253 year: 2000 end-page: 265 ident: bib41 article-title: Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice publication-title: Int. J. Dev. Biol. contributor: fullname: Mummery – volume: 69 start-page: 597 year: 2006 end-page: 607 ident: bib23 article-title: Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression publication-title: Mol. Pharmacol. contributor: fullname: Tamaki – volume: 8 start-page: 671 year: 2001 end-page: 682 ident: bib39 article-title: The TGF publication-title: Mol. Cell contributor: fullname: Massagué – volume: 10 start-page: 133 year: 2014 end-page: 140 ident: bib46 article-title: Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway publication-title: Nat. Chem. Biol. contributor: fullname: Bian – volume: 371 start-page: 1374 year: 2021 end-page: 1378 ident: bib44 article-title: SARS-CoV-2 M publication-title: Science contributor: fullname: Shen – volume: 29 start-page: 265 year: 2004 end-page: 273 ident: bib22 article-title: New insights into TGF-β–Smad signalling publication-title: Trends Biochem. Sci. contributor: fullname: Hill – volume: 65 start-page: 280 year: 2022 end-page: 294 ident: bib7 article-title: Overview of SARS-CoV-2 genome-encoded proteins publication-title: Sci. China Life Sci. contributor: fullname: Gao – volume: 18 start-page: 9 year: 2021 end-page: 34 ident: bib43 article-title: TGFβ biology in cancer progression and immunotherapy publication-title: Nat. Rev. Clin. Oncol. contributor: fullname: Akhurst – volume: 100 start-page: 768 year: 1997 end-page: 776 ident: bib16 article-title: Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung publication-title: J. Clin. Invest. contributor: fullname: Gauldie – volume: 48 start-page: 3164 year: 2005 end-page: 3170 ident: bib45 article-title: A bioavailability score publication-title: J. Med. Chem. contributor: fullname: Martin – volume: 147 start-page: 79 year: 2019 end-page: 91 ident: bib32 article-title: Inflammation and immunity in IPF pathogenesis and treatment publication-title: Respir. Med. contributor: fullname: Kool – volume: 496 start-page: 445 year: 2013 end-page: 455 ident: bib26 article-title: Macrophage biology in development, homeostasis and disease publication-title: Nature contributor: fullname: Pollard – volume: 16 start-page: 5353 year: 1997 end-page: 5362 ident: bib25 article-title: TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4 publication-title: EMBO J. contributor: fullname: ten Dijke – volume: 15 start-page: 6231 year: 1996 end-page: 6240 ident: bib18 article-title: Phosphorylation of Ser165 in TGF-beta type I receptor modulates TGF-beta1-induced cellular responses publication-title: EMBO J. contributor: fullname: Heldin – volume: 27 start-page: 601 year: 2021 end-page: 615 ident: bib3 article-title: Post-acute COVID-19 syndrome publication-title: Nat. Med. contributor: fullname: Sehrawat – volume: 11 start-page: 519 year: 2011 end-page: 531 ident: bib27 article-title: Neutrophils in the activation and regulation of innate and adaptive immunity publication-title: Nat. Rev. Immunol. contributor: fullname: Jaillon – volume: 208 start-page: 1339 year: 2011 end-page: 1350 ident: bib40 article-title: Integrating mechanisms of pulmonary fibrosis publication-title: J. Exp. Med. contributor: fullname: Wynn – volume: 41 start-page: 467 year: 1988 end-page: 470 ident: bib17 article-title: Simple method of estimating severity of pulmonary fibrosis on a numerical scale publication-title: J. Clin. Pathol. contributor: fullname: Timbrell – volume: 1809 start-page: 17 year: 2018 end-page: 30 ident: bib48 article-title: Overview of innate lung immunity and inflammation publication-title: Methods Mol. Biol. contributor: fullname: Martin – volume: 2 start-page: 103 year: 2009 end-page: 121 ident: bib15 article-title: Pulmonary fibrosis: pathogenesis, etiology and regulation publication-title: Mucosal Immunol. contributor: fullname: Wynn – volume: 9 year: 2022 ident: bib33 article-title: SARS-CoV-2 N protein induces acute kidney injury via smad3-dependent G1 cell cycle arrest mechanism publication-title: Adv. Sci. contributor: fullname: Lan – volume: 96 start-page: 425 year: 1999 end-page: 436 ident: bib38 article-title: Crystal structure of the cytoplasmic domain of the type I TGF publication-title: cell contributor: fullname: Kuriyan – volume: 386 start-page: 1532 year: 2022 end-page: 1546 ident: bib30 article-title: Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant publication-title: N. Engl. J. Med. contributor: fullname: O'Connell – volume: 23 start-page: 718 year: 2021 end-page: 732 ident: bib10 article-title: Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity publication-title: Nat. Cell Biol. contributor: fullname: Zhou – volume: 12 start-page: 325 year: 2016 end-page: 338 ident: bib11 article-title: TGF-β: the master regulator of fibrosis publication-title: Nat. Rev. Nephrol. contributor: fullname: Lan – volume: 9 start-page: 747 year: 2021 end-page: 754 ident: bib6 article-title: 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study publication-title: Lancet Respir. Med. contributor: fullname: Ding – volume: 586 start-page: 1885 year: 2012 end-page: 1896 ident: bib35 article-title: Oligomeric interactions of TGF-β and BMP receptors publication-title: FEBS Lett. contributor: fullname: Henis – volume: 20 start-page: 270 year: 2022 end-page: 284 ident: bib1 article-title: SARS-CoV-2 pathogenesis publication-title: Nat. Rev. Microbiol. contributor: fullname: Haagmans – volume: 8 start-page: a022103 year: 2016 ident: bib34 article-title: Structural biology and evolution of the TGF-β family publication-title: Cold Spring Harbor Perspect. Biol. contributor: fullname: Springer – volume: 80 start-page: 1092 year: 2020 end-page: 1103.e4 ident: bib8 article-title: Phosphoregulation of phase separation by the SARS-CoV-2 N protein suggests a biophysical basis for its dual functions publication-title: Mol. Cell contributor: fullname: Morgan – volume: 302 start-page: 228 year: 2021 end-page: 240 ident: bib5 article-title: COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts publication-title: Immunol. Rev. contributor: fullname: Tatler – volume: 78 start-page: 1192 year: 2020 end-page: 1206.e10 ident: bib47 article-title: Ectosomal PKM2 promotes HCC by inducing macrophage differentiation and remodeling the tumor microenvironment publication-title: Mol. Cell contributor: fullname: Wang – volume: 184 start-page: 6243 year: 2021 end-page: 6261.e27 ident: bib12 article-title: SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis publication-title: Cell contributor: fullname: Timm – volume: 86 start-page: 116 year: 2006 end-page: 129 ident: bib42 article-title: Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development publication-title: Lab. Invest. contributor: fullname: Oh – volume: 19 start-page: 8 year: 2009 end-page: 20 ident: bib37 article-title: Phospho-control of TGF-β superfamily signaling publication-title: Cell Res. contributor: fullname: Feng – volume: 8 start-page: 14420 year: 2017 ident: bib49 article-title: Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation publication-title: Nat. Commun. contributor: fullname: Chen – volume: 595 start-page: 107 year: 2021 end-page: 113 ident: bib13 article-title: COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets publication-title: Nature contributor: fullname: Montoro – volume: 586 start-page: 1885 year: 2012 ident: 10.1016/j.chembiol.2023.02.004_bib35 article-title: Oligomeric interactions of TGF-β and BMP receptors publication-title: FEBS Lett. doi: 10.1016/j.febslet.2012.01.040 contributor: fullname: Ehrlich – volume: 12 start-page: 2730 year: 2001 ident: 10.1016/j.chembiol.2023.02.004_bib14 article-title: Alpha-smooth muscle actin expression upregulates fibroblast contractile activity publication-title: Mol. Biol. Cell doi: 10.1091/mbc.12.9.2730 contributor: fullname: Hinz – volume: 26 start-page: 1636 year: 2020 ident: 10.1016/j.chembiol.2023.02.004_bib28 article-title: An inflammatory cytokine signature predicts COVID-19 severity and survival publication-title: Nat. Med. doi: 10.1038/s41591-020-1051-9 contributor: fullname: Del Valle – volume: 12 year: 2019 ident: 10.1016/j.chembiol.2023.02.004_bib36 article-title: Specificity, versatility, and control of TGF-β family signaling publication-title: Sci. Signal. doi: 10.1126/scisignal.aav5183 contributor: fullname: Derynck – volume: 386 start-page: 1532 year: 2022 ident: 10.1016/j.chembiol.2023.02.004_bib30 article-title: Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2119451 contributor: fullname: Andrews – volume: 20 start-page: 270 year: 2022 ident: 10.1016/j.chembiol.2023.02.004_bib1 article-title: SARS-CoV-2 pathogenesis publication-title: Nat. Rev. Microbiol. doi: 10.1038/s41579-022-00713-0 contributor: fullname: Lamers – volume: 8 start-page: 807 year: 2020 ident: 10.1016/j.chembiol.2023.02.004_bib4 article-title: Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy publication-title: Lancet Respir. Med. doi: 10.1016/S2213-2600(20)30225-3 contributor: fullname: George – volume: 96 start-page: 425 year: 1999 ident: 10.1016/j.chembiol.2023.02.004_bib38 article-title: Crystal structure of the cytoplasmic domain of the type I TGFNL receptor in complex with FKBP12 publication-title: cell doi: 10.1016/S0092-8674(00)80555-3 contributor: fullname: Huse – volume: 11 start-page: 519 year: 2011 ident: 10.1016/j.chembiol.2023.02.004_bib27 article-title: Neutrophils in the activation and regulation of innate and adaptive immunity publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3024 contributor: fullname: Mantovani – volume: 496 start-page: 445 year: 2013 ident: 10.1016/j.chembiol.2023.02.004_bib26 article-title: Macrophage biology in development, homeostasis and disease publication-title: Nature doi: 10.1038/nature12034 contributor: fullname: Wynn – volume: 302 start-page: 228 year: 2021 ident: 10.1016/j.chembiol.2023.02.004_bib5 article-title: COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts publication-title: Immunol. Rev. doi: 10.1111/imr.12977 contributor: fullname: John – volume: 100 start-page: 768 year: 1997 ident: 10.1016/j.chembiol.2023.02.004_bib16 article-title: Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung publication-title: J. Clin. Invest. doi: 10.1172/JCI119590 contributor: fullname: Sime – volume: 425 start-page: 577 year: 2003 ident: 10.1016/j.chembiol.2023.02.004_bib21 article-title: Smad-dependent and Smad-independent pathways in TGF-b family signalling publication-title: Nature doi: 10.1038/nature02006 contributor: fullname: Derynck – volume: 10 start-page: 133 year: 2014 ident: 10.1016/j.chembiol.2023.02.004_bib46 article-title: Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.1406 contributor: fullname: Wang – volume: 23 start-page: 718 year: 2021 ident: 10.1016/j.chembiol.2023.02.004_bib10 article-title: Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity publication-title: Nat. Cell Biol. doi: 10.1038/s41556-021-00710-0 contributor: fullname: Wang – volume: 12 start-page: 325 year: 2016 ident: 10.1016/j.chembiol.2023.02.004_bib11 article-title: TGF-β: the master regulator of fibrosis publication-title: Nat. Rev. Nephrol. doi: 10.1038/nrneph.2016.48 contributor: fullname: Meng – volume: 80 start-page: 1092 year: 2020 ident: 10.1016/j.chembiol.2023.02.004_bib8 article-title: Phosphoregulation of phase separation by the SARS-CoV-2 N protein suggests a biophysical basis for its dual functions publication-title: Mol. Cell doi: 10.1016/j.molcel.2020.11.025 contributor: fullname: Carlson – volume: 29 start-page: 265 year: 2004 ident: 10.1016/j.chembiol.2023.02.004_bib22 article-title: New insights into TGF-β–Smad signalling publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2004.03.008 contributor: fullname: Dijke – volume: 16 start-page: 5353 year: 1997 ident: 10.1016/j.chembiol.2023.02.004_bib25 article-title: TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4 publication-title: EMBO J. doi: 10.1093/emboj/16.17.5353 contributor: fullname: Nakao – volume: 147 start-page: 79 year: 2019 ident: 10.1016/j.chembiol.2023.02.004_bib32 article-title: Inflammation and immunity in IPF pathogenesis and treatment publication-title: Respir. Med. doi: 10.1016/j.rmed.2018.12.015 contributor: fullname: Heukels – volume: 48 start-page: 3164 year: 2005 ident: 10.1016/j.chembiol.2023.02.004_bib45 article-title: A bioavailability score publication-title: J. Med. Chem. doi: 10.1021/jm0492002 contributor: fullname: Martin – volume: 78 start-page: 1192 year: 2020 ident: 10.1016/j.chembiol.2023.02.004_bib47 article-title: Ectosomal PKM2 promotes HCC by inducing macrophage differentiation and remodeling the tumor microenvironment publication-title: Mol. Cell doi: 10.1016/j.molcel.2020.05.004 contributor: fullname: Hou – volume: 2 start-page: 103 year: 2009 ident: 10.1016/j.chembiol.2023.02.004_bib15 article-title: Pulmonary fibrosis: pathogenesis, etiology and regulation publication-title: Mucosal Immunol. doi: 10.1038/mi.2008.85 contributor: fullname: Wilson – volume: 208 start-page: 1339 year: 2011 ident: 10.1016/j.chembiol.2023.02.004_bib40 article-title: Integrating mechanisms of pulmonary fibrosis publication-title: J. Exp. Med. doi: 10.1084/jem.20110551 contributor: fullname: Wynn – volume: 69 start-page: 597 year: 2006 ident: 10.1016/j.chembiol.2023.02.004_bib23 article-title: Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression publication-title: Mol. Pharmacol. doi: 10.1124/mol.105.017483 contributor: fullname: Jinnin – volume: 9 start-page: 747 year: 2021 ident: 10.1016/j.chembiol.2023.02.004_bib6 article-title: 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study publication-title: Lancet Respir. Med. doi: 10.1016/S2213-2600(21)00174-0 contributor: fullname: Wu – volume: 595 start-page: 107 year: 2021 ident: 10.1016/j.chembiol.2023.02.004_bib13 article-title: COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets publication-title: Nature doi: 10.1038/s41586-021-03570-8 contributor: fullname: Delorey – volume: 8 start-page: 671 year: 2001 ident: 10.1016/j.chembiol.2023.02.004_bib39 article-title: The TGFNL receptor activation process: an inhibitor- to substrate-binding switch publication-title: Mol. Cell doi: 10.1016/S1097-2765(01)00332-X contributor: fullname: Huse – volume: 86 start-page: 116 year: 2006 ident: 10.1016/j.chembiol.2023.02.004_bib42 article-title: Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development publication-title: Lab. Invest. doi: 10.1038/labinvest.3700376 contributor: fullname: Seki – volume: 18 start-page: 9 year: 2021 ident: 10.1016/j.chembiol.2023.02.004_bib43 article-title: TGFβ biology in cancer progression and immunotherapy publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/s41571-020-0403-1 contributor: fullname: Derynck – volume: 15 start-page: 6231 year: 1996 ident: 10.1016/j.chembiol.2023.02.004_bib18 article-title: Phosphorylation of Ser165 in TGF-beta type I receptor modulates TGF-beta1-induced cellular responses publication-title: EMBO J. doi: 10.1002/j.1460-2075.1996.tb01013.x contributor: fullname: Souchelnytskyi – volume: 282 start-page: 18327 year: 2007 ident: 10.1016/j.chembiol.2023.02.004_bib24 article-title: Activation of Mps1 promotes transforming growth factor-β-independent Smad signaling publication-title: J. Biol. Chem. doi: 10.1074/jbc.M700636200 contributor: fullname: Zhu – volume: 19 start-page: 8 year: 2009 ident: 10.1016/j.chembiol.2023.02.004_bib37 article-title: Phospho-control of TGF-β superfamily signaling publication-title: Cell Res. doi: 10.1038/cr.2008.327 contributor: fullname: Wrighton – volume: 45 start-page: 525 year: 1994 ident: 10.1016/j.chembiol.2023.02.004_bib29 article-title: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy publication-title: Kidney Int. doi: 10.1038/ki.1994.68 contributor: fullname: Tamaki – volume: 16 start-page: 3866 year: 1997 ident: 10.1016/j.chembiol.2023.02.004_bib19 article-title: Mechanism of TGFβ receptor inhibition by FKBP12 publication-title: EMBO J. doi: 10.1093/emboj/16.13.3866 contributor: fullname: Chen – volume: 8 start-page: 14420 year: 2017 ident: 10.1016/j.chembiol.2023.02.004_bib49 article-title: Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation publication-title: Nat. Commun. doi: 10.1038/ncomms14420 contributor: fullname: Bian – volume: 241 start-page: 13 year: 2022 ident: 10.1016/j.chembiol.2023.02.004_bib31 article-title: From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? publication-title: Transl. Res. doi: 10.1016/j.trsl.2021.09.001 contributor: fullname: Michalski – volume: 41 start-page: 467 year: 1988 ident: 10.1016/j.chembiol.2023.02.004_bib17 article-title: Simple method of estimating severity of pulmonary fibrosis on a numerical scale publication-title: J. Clin. Pathol. doi: 10.1136/jcp.41.4.467 contributor: fullname: Ashcroft – volume: 27 start-page: 601 year: 2021 ident: 10.1016/j.chembiol.2023.02.004_bib3 article-title: Post-acute COVID-19 syndrome publication-title: Nat. Med. doi: 10.1038/s41591-021-01283-z contributor: fullname: Nalbandian – volume: 1809 start-page: 17 year: 2018 ident: 10.1016/j.chembiol.2023.02.004_bib48 article-title: Overview of innate lung immunity and inflammation publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-8570-8_2 contributor: fullname: Riches – volume: 65 start-page: 280 year: 2022 ident: 10.1016/j.chembiol.2023.02.004_bib7 article-title: Overview of SARS-CoV-2 genome-encoded proteins publication-title: Sci. China Life Sci. doi: 10.1007/s11427-021-1964-4 contributor: fullname: Bai – volume: 371 start-page: 1374 year: 2021 ident: 10.1016/j.chembiol.2023.02.004_bib44 article-title: SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model publication-title: Science doi: 10.1126/science.abf1611 contributor: fullname: Qiao – volume: 184 start-page: 6243 year: 2021 ident: 10.1016/j.chembiol.2023.02.004_bib12 article-title: SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis publication-title: Cell doi: 10.1016/j.cell.2021.11.033 contributor: fullname: Wendisch – volume: 9 start-page: 1216 issue: 1 year: 2018 ident: 10.1016/j.chembiol.2023.02.004_bib20 article-title: The orphan GPR50 receptor promotes constitutive TGFβ receptor signaling and protects against cancer development publication-title: Nat. Commun. doi: 10.1038/s41467-018-03609-x contributor: fullname: Wojciech – volume: 44 start-page: 253 year: 2000 ident: 10.1016/j.chembiol.2023.02.004_bib41 article-title: Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice publication-title: Int. J. Dev. Biol. contributor: fullname: Goumans – volume: 8 start-page: a022103 year: 2016 ident: 10.1016/j.chembiol.2023.02.004_bib34 article-title: Structural biology and evolution of the TGF-β family publication-title: Cold Spring Harbor Perspect. Biol. doi: 10.1101/cshperspect.a022103 contributor: fullname: Hinck – volume: 19 start-page: 685 year: 2021 ident: 10.1016/j.chembiol.2023.02.004_bib9 article-title: Structural biology of SARS-CoV-2 and implications for therapeutic development publication-title: Nat. Rev. Microbiol. doi: 10.1038/s41579-021-00630-8 contributor: fullname: Yang – volume: 395 start-page: 470 year: 2020 ident: 10.1016/j.chembiol.2023.02.004_bib2 article-title: A novel coronavirus outbreak of global health concern publication-title: Lancet doi: 10.1016/S0140-6736(20)30185-9 contributor: fullname: Wang – volume: 9 year: 2022 ident: 10.1016/j.chembiol.2023.02.004_bib33 article-title: SARS-CoV-2 N protein induces acute kidney injury via smad3-dependent G1 cell cycle arrest mechanism publication-title: Adv. Sci. contributor: fullname: Wang |
SSID | ssj0001637137 |
Score | 2.4586902 |
Snippet | Pulmonary fibrosis is a typical sequela of coronavirus disease 2019 (COVID-19), which is linked with a poor prognosis for COVID-19 patients. However, the... |
SourceID | pubmedcentral crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 261 |
SubjectTerms | Animals compound RMY-205 COVID-19 - complications Fibrosis Mice N protein Nucleocapsid Proteins - therapeutic use pulmonary fibrosis Pulmonary Fibrosis - complications Pulmonary Fibrosis - drug therapy SARS-CoV-2 TGF-β/Smad pathway |
Title | Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein |
URI | https://dx.doi.org/10.1016/j.chembiol.2023.02.004 https://www.ncbi.nlm.nih.gov/pubmed/36889311 https://pubmed.ncbi.nlm.nih.gov/PMC9990178 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDLZgXLgg3oyXckDcwvpIm_Y4JhAChhADBKdqSRPRCdoKxmH_HrsPYCcOXCr1YTWy3fhzan8BOIoUgX6qeQqjmIvI01y5YciFNCmGT5E6Y1rQH96EFw_i8il4WoBB2wtDZZXN3F_P6dVs3VzpNdrslVnWG3nEjEIA3q87ShdhyZOh43VgqX_6eHX9s9QS-rJmzyQRTjK_eoUnJ6idN6I8OqGtxGsGT_FnmJovofwVk85XYaUBk6xfj3cNFky-Dhv9HBPptxk7ZlV5Z7VuvgHZ_U-nFSsLgsozVlhGNeW0tRK7Gz6jMwcMUSwrP1_RPcfvM2YxnS4-sg-GuTt6QcrUjI36dyM-KB65x3KiQ8ZwWKJTs4rzIcs34eH87H5wwZt9FrjG0DTlY-l6NvWsQXTlaDeKjROnkQ6stb7QqQ61lCrA3EJbMzapNGRSawxlM1LhnS3o5EVudoApR5lYaBflfIHgT7mRJcJ3KTTikiDtQq9Va1LWdBpJW2c2SVpDJGSIxPESNEQX4lb7yZxjJDjn_ym7XVvp-11-GCFAc90uyDn7fT9AbNvzd_LspWLdjukPoox2_zGePVimM159GvvQmb5_mgPENFN12PjsIUWWAI83t8MvS734aQ |
link.rule.ids | 230,315,786,790,891,27602,27957,27958,45698 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LU9swEN6h4dBeOi30kT6oDkxvIn7IlnxMM2VCSTiQwNCTJpKlqZlieyAc8u-76weQE4cebXnHmt219lt59xPAoTIE-qnmKVUZFyqy3IRpyoV0OYZPkQcr2tCfn6XTC_HrKrnagUnfC0Nlld3a367pzWrd3Rl12hzVRTFaRMSMQgA-bjtKX8AuXmVqALvjH5ens8etljSWLXsmiXCSedIrfH2E2rkhyqMjOkq8ZfAUz4ap7RLKJzHp-A287sAkG7fzfQs7rtyD_XGJifTNhn1nTXlns2--D8XysdOK1RVB5Q2rPKOacjpaiZ3Pf6MzJwxRLKvv_6J7rm43zGM6Xd0Vdwxzd_SCnJkNW4zPF3xSXfKIlUSHjOGwRqdmDedDUb6Di-Ofy8mUd-cscIuhac1XMox8HnmH6CqwocpckOXKJt77WNjcplZKk2BuYb1buVw6Mql3jrIZaXDkPQzKqnQfgZnAuEzYEOVigeDPhMoT4bsUFnFJkg9h1KtV1y2dhu7rzK51bwhNhtBBpNEQQ8h67estx9C45j8r-6G10sO74lQhQAvDIcgt-z08QGzb2yNl8adh3c7oD6JUn_5jPt_g5XQ5n-nZydnpZ3hFI7z5TL7AYH17774ivlmbg85__wGKyflw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Therapeutic+potency+of+compound+RMY-205+for+pulmonary+fibrosis+induced+by+SARS-CoV-2+nucleocapsid+protein&rft.jtitle=Cell+chemical+biology&rft.au=Zhang%2C+Zhi-yuan&rft.au=Ju%2C+Cui-yu&rft.au=Wu%2C+Liu-zheng&rft.au=Yan%2C+Han&rft.date=2023-03-16&rft.pub=Elsevier+Ltd&rft.issn=2451-9456&rft.eissn=2451-9456&rft_id=info:doi/10.1016%2Fj.chembiol.2023.02.004&rft.externalDBID=PMC9990178 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2451-9456&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2451-9456&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2451-9456&client=summon |